CeloNova: COBRA PzF NanoCoated Coronary Stent Demonstrates Exceptional Long-Term Safety and Low ID-TLR at Five Years in Highly Complex Patients Undergoing PCI
Positive results from the landmark PzF SHIELD IDE clinical trial reinforce safe and effective use in a real-world clinical practice of the world's...
Read full article »
CEO
CeloNova is a California-based healthcare equipment company that manufactures and markets interventional cardiology and endovascular products for the healthcare industry.
Read more